Quick Answer
CARLSMED, INC. reported R&D Expense of $17.02 million for fiscal year 2025.
CARLSMED, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $17.02M | +19.0% |
| 2024 | $14.30M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.45M | +10.2% | +6.9% |
| June 30, 2025 | $4.16M | +4.1% | +3.1% |
| September 30, 2024 | $4.04M | — | +0.9% |
| June 30, 2024 | $4.00M | — | — |
- CARLSMED, INC. showed an increase of +19.0% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, CARLSMED, INC.’s r&d expense has grown by 19.0% (from $14.30 million to $17.02 million).
- The most recent figure is from CARLSMED, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: